VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible psychedelic and functional mushrooms, as well as synthetic formulations for transformational human experiences, is pleased to announce that it has entered into a supply…

Source

Previous articleHAVN Life Enters Supply Agreement with MPB Group Inc.
Next articleMindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation